| 2023-05-08 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Cell & Genetic Therapies | 2,850 0.0011% | $350.00 | $997,500 | +5% | |
| 2023-05-05 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Cell & Genetic Therapies | 422 0.0002% | $350.03 | $147,713 | +3.59% | |
| 2023-05-03 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Cell & Genetic Therapies | 2,781 0.0011% | $350.74 | $975,418 | +3.64% | |
| 2023-05-02 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Cell & Genetic Therapies | 1,622 0.0006% | $350.66 | $568,768 | +3.62% | |
| 2023-04-12 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Cell & Genetic Therapies | 7,567 0.0029% | $326.70 | $2.47M | +8.63% | |
| 2023-04-04 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Cell & Genetic Therapies | 522 0.0002% | $315.81 | $164,854 | +12.37% | |
| 2023-03-16 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Cell & Genetic Therapies | 2,746 0.0011% | $300.59 | $825,423 | +16.81% | |
| 2023-02-14 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Cell & Genetic Therapies | 2,181 0.0008% | $300.39 | $655,161 | +16.39% | |
| 2023-02-13 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Cell & Genetic Therapies | 113 <0.0001% | $300.39 | $33,944 | +16.78% | |
| 2023-01-31 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Cell & Genetic Therapies | 106 <0.0001% | $325.00 | $34,450 | +7.76% | |
| 2022-11-02 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Cell & Genetic Therapies | 320 0.0001% | $312.64 | $100,045 | +7.45% | |
| 2022-10-18 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Cell & Genetic Therapies | 1,791 0.0007% | $300.31 | $537,860 | +8.27% | |
| 2022-05-16 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Cell & Genetic Therapies | 8 <0.0001% | $254.44 | $2,036 | +15.78% | |
| 2022-05-04 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Cell & Genetic Therapies | 36 <0.0001% | $275.09 | $9,903 | +7.22% | |
| 2022-05-02 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Cell & Genetic Therapies | 4 <0.0001% | $264.37 | $1,057 | +11.94% | |
| 2022-04-07 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Cell & Genetic Therapies | 327 0.0001% | $276.39 | $90,380 | +5.58% | |
| 2022-04-04 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Cell & Genetic Therapies | 305 0.0001% | $267.10 | $81,466 | +8.33% | |
| 2022-03-17 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Cell & Genetic Therapies | 2,122 0.0008% | $250.06 | $530,627 | +15.88% | |
| 2022-02-02 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Cell & Genetic Therapies | 1,040 0.0004% | $250.98 | $261,017 | +12.81% | |
| 2021-05-17 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Cell & Genetic Therapies | 112 <0.0001% | $216.34 | $24,230 | -4.41% |